Literature DB >> 24832565

Candidemia and non-candidemia related septic shock: are there differences between them?

Marin H Kollef1, José-Artur Paiva, Pierre-Emmanuel Charles.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24832565     DOI： 10.1007/s00134-014-3332-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

1.  Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.

Authors:  Kevin W Garey; Milind Rege; Manjunath P Pai; Dana E Mingo; Katie J Suda; Robin S Turpin; David T Bearden
Journal:  Clin Infect Dis       Date:  2006-05-16       Impact factor: 9.079

Review 2.  Enhancing molecular approaches for diagnosis of fungal infections.

Authors:  Sean X Zhang
Journal:  Future Microbiol       Date:  2013-12       Impact factor: 3.165

3.  A randomized trial of protocol-based care for early septic shock.

Authors:  Donald M Yealy; John A Kellum; David T Huang; Amber E Barnato; Lisa A Weissfeld; Francis Pike; Thomas Terndrup; Henry E Wang; Peter C Hou; Frank LoVecchio; Michael R Filbin; Nathan I Shapiro; Derek C Angus
Journal:  N Engl J Med       Date:  2014-03-18       Impact factor: 91.245

4.  Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes.

Authors:  Shellee A Grim; Karen Berger; Christine Teng; Sandeep Gupta; Jennifer E Layden; William M Janda; Nina M Clark
Journal:  J Antimicrob Chemother       Date:  2011-12-18       Impact factor: 5.790

5.  Systemic antifungal therapy in critically ill patients without invasive fungal infection*.

Authors:  Elie Azoulay; Hervé Dupont; Alexis Tabah; Olivier Lortholary; Jean-Paul Stahl; Adrien Francais; Claude Martin; Bertand Guidet; Jean-François Timsit
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

6.  MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.

Authors:  Luis Ostrosky-Zeichner; Shmuel Shoham; Jose Vazquez; Annette Reboli; Robert Betts; Michelle A Barron; Mindy Schuster; Marc A Judson; Sanjay G Revankar; Juan Pablo Caeiro; Julie E Mangino; David Mushatt; Roger Bedimo; Alison Freifeld; Minh Hong Nguyen; Carol A Kauffman; William E Dismukes; Andrew O Westfall; Jeanna Beth Deerman; Craig Wood; Jack D Sobel; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2014-02-18       Impact factor: 9.079

7.  A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality.

Authors:  Matteo Bassetti; Elda Righi; Filippo Ansaldi; Maria Merelli; Cecilia Trucchi; Trucchi Cecilia; Gennaro De Pascale; Ana Diaz-Martin; Roberto Luzzati; Chiara Rosin; Leonel Lagunes; Enrico Maria Trecarichi; Maurizio Sanguinetti; Brunella Posteraro; Jose Garnacho-Montero; Assunta Sartor; Jordi Rello; Giorgio Della Rocca; Massimo Antonelli; Mario Tumbarello
Journal:  Intensive Care Med       Date:  2014-05-08       Impact factor: 17.440

8.  Treatment-related risk factors for hospital mortality in Candida bloodstream infections.

Authors:  Andrew J Labelle; Scott T Micek; Nareg Roubinian; Marin H Kollef
Journal:  Crit Care Med       Date:  2008-11       Impact factor: 7.598

9.  Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.

Authors:  Mindy G Schuster; John E Edwards; Jack D Sobel; Rabih O Darouiche; Adolf W Karchmer; Susan Hadley; Gus Slotman; Helene Panzer; Pinaki Biswas; John H Rex
Journal:  Ann Intern Med       Date:  2008-07-15       Impact factor: 25.391

10.  β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.

Authors:  Frederic Tissot; Frederic Lamoth; Philippe M Hauser; Christina Orasch; Ursula Flückiger; Martin Siegemund; Stefan Zimmerli; Thierry Calandra; Jacques Bille; Philippe Eggimann; Oscar Marchetti
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.